Antiviral Immunity and Virus-Mediated Antagonism in Disease Vector Mosquitoes

Glady Hazitha Samuel1, Zach N Adelman1, Kevin M Myles1

  • 1Texas A & M University, Department of Entomology, Minnie Belle Heep Center, College Station, TX 77843-2475, USA.

Trends in Microbiology
|February 4, 2018
PubMed

Insights

Arthropod-borne viruses (arboviruses) cause significant global health burdens. This review explores mosquito antiviral immunity and how viruses may overcome it, suggesting an evolutionary arms race between viruses and their insect vectors.

Area of Science:

  • Virology
  • Immunology
  • Vector Biology

Background:

  • Arthropod-borne viruses (arboviruses) cause widespread human and animal diseases.
  • Transmission involves replication in both vertebrate and invertebrate hosts.
  • Examples include Zika, dengue, and West Nile viruses.

Purpose of the Study:

  • To review antiviral immune pathways in mosquitoes.
  • To discuss viral antagonism of these pathways.
  • To explore the evolutionary dynamics between arboviruses and mosquito vectors.

Main Methods:

  • Literature review focusing on mosquito antiviral immunity.
  • Analysis of viral mechanisms for immune evasion.
  • Discussion of co-evolutionary perspectives.

Main Results:

  • Mosquitoes possess innate antiviral immune mechanisms.
  • Arboviruses have evolved strategies to antagonize mosquito immunity.
  • Evidence suggests an ongoing evolutionary "arms race".

Conclusions:

  • Understanding mosquito antiviral immunity is crucial for controlling arbovirus transmission.
  • Viral antagonism and co-evolution shape arbovirus epidemiology.
  • Further research into vector-pathogen interactions can inform public health strategies.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
84.4K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
What is the Immune System?01:38

What is the Immune System?

Overview
133.1K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.8K
What are Viruses?00:50

What are Viruses?

Overview
128.5K